Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Lysophosphatidic Acid Receptor 1 Antagonist SAR100842 for Patients With Diffuse Cutaneous Systemic Sclerosis: A Double-Blind, Randomized, Eight-Week Placebo-Controlled Study Followed by a Sixteen-Week Open-Label Extension Study.

Allanore Y, Distler O, Jagerschmidt A, Illiano S, Ledein L, Boitier E, Agueusop I, Denton CP, Khanna D.

Arthritis Rheumatol. 2018 Oct;70(10):1634-1643. doi: 10.1002/art.40547. Epub 2017 Nov 6.

PMID:
29732731
2.

Two approaches for estimating the lower limit of quantitation (LLOQ) of microRNA levels assayed as exploratory biomarkers by RT-qPCR.

Wolfinger RD, Beedanagari S, Boitier E, Chen T, Couttet P, Ellinger-Ziegelbauer H, Guillemain G, Mariet C, Mouritzen P, O'Lone R, Pine PS, Sharapova T, Yan J, Yuen PS, Thompson KL.

BMC Biotechnol. 2018 Feb 2;18(1):6. doi: 10.1186/s12896-018-0415-4.

3.

Next-Generation Sequencing to Investigate Urinary microRNAs from Macaca fascicularis (Cynomolgus Monkey).

Veeranagouda Y, Léonard JF, Gautier JC, Boitier E.

Methods Mol Biol. 2017;1641:349-378. doi: 10.1007/978-1-4939-7172-5_20.

PMID:
28748475
4.

Absolute Measurement of Cardiac Injury-Induced microRNAs in Biofluids across Multiple Test Sites.

Thompson KL, Boitier E, Chen T, Couttet P, Ellinger-Ziegelbauer H, Goetschy M, Guillemain G, Kanki M, Kelsall J, Mariet C, de La Moureyre-Spire C, Mouritzen P, Nassirpour R, O'Lone R, Pine PS, Rosenzweig BA, Sharapova T, Smith A, Uchiyama H, Yan J, Yuen PS, Wolfinger R.

Toxicol Sci. 2016 Nov;154(1):115-125. Epub 2016 Sep 7.

PMID:
27605421
5.

Correction: Identification of microRNAs in Macaca fascicularis (Cynomolgus Monkey) by Homology Search and Experimental Validation by Small RNA-Seq and RT-qPCR Using Kidney Cortex Tissues.

Veeranagouda Y, Rival P, Prades C, Mariet C, Léonard JF, Gautier JC, Zhou X, Wang J, Li B, Ozoux ML, Boitier E.

PLoS One. 2016 Oct 3;11(10):e0164317. doi: 10.1371/journal.pone.0164317. eCollection 2016.

6.

Evaluation of novel biomarkers of nephrotoxicity in Cynomolgus monkeys treated with gentamicin.

Gautier JC, Zhou X, Yang Y, Gury T, Qu Z, Palazzi X, Léonard JF, Slaoui M, Veeranagouda Y, Guizon I, Boitier E, Filali-Ansary A, van den Berg BHJ, Poetz O, Joos T, Zhang T, Wang J, Detilleux P, Li B.

Toxicol Appl Pharmacol. 2016 Jul 15;303:1-10. doi: 10.1016/j.taap.2016.04.012. Epub 2016 Apr 19.

PMID:
27105553
7.

Identification of microRNAs in Macaca fascicularis (Cynomolgus Monkey) by Homology Search and Experimental Validation by Small RNA-Seq and RT-qPCR Using Kidney Cortex Tissues.

Veeranagouda Y, Rival P, Prades C, Mariet C, Léonard JF, Gautier JC, Zhou X, Wang J, Li B, Ozoux ML, Boitier E.

PLoS One. 2015 Nov 12;10(11):e0142708. doi: 10.1371/journal.pone.0142708. eCollection 2015. Erratum in: PLoS One. 2016 Oct 3;11(10 ):e0164317.

8.

Integrated transcriptomic and proteomic evaluation of gentamicin nephrotoxicity in rats.

Com E, Boitier E, Marchandeau JP, Brandenburg A, Schroeder S, Hoffmann D, Mally A, Gautier JC.

Toxicol Appl Pharmacol. 2012 Jan 1;258(1):124-33. doi: 10.1016/j.taap.2011.10.015. Epub 2011 Oct 29.

PMID:
22061828
9.

Development and evaluation of a genomic signature for the prediction and mechanistic assessment of nongenotoxic hepatocarcinogens in the rat.

Fielden MR, Adai A, Dunn RT 2nd, Olaharski A, Searfoss G, Sina J, Aubrecht J, Boitier E, Nioi P, Auerbach S, Jacobson-Kram D, Raghavan N, Yang Y, Kincaid A, Sherlock J, Chen SJ, Car B; Predictive Safety Testing Consortium, Carcinogenicity Working Group.

Toxicol Sci. 2011 Nov;124(1):54-74. doi: 10.1093/toxsci/kfr202. Epub 2011 Aug 2.

PMID:
21813463
10.

A comparative integrated transcript analysis and functional characterization of differential mechanisms for induction of liver hypertrophy in the rat.

Boitier E, Amberg A, Barbié V, Blichenberg A, Brandenburg A, Gmuender H, Gruhler A, McCarthy D, Meyer K, Riefke B, Raschke M, Schoonen W, Sieber M, Suter L, Thomas CE, Sajot N.

Toxicol Appl Pharmacol. 2011 Apr 15;252(2):85-96. doi: 10.1016/j.taap.2011.01.021. Epub 2011 Feb 26.

PMID:
21315101
11.

EU framework 6 project: predictive toxicology (PredTox)--overview and outcome.

Suter L, Schroeder S, Meyer K, Gautier JC, Amberg A, Wendt M, Gmuender H, Mally A, Boitier E, Ellinger-Ziegelbauer H, Matheis K, Pfannkuch F.

Toxicol Appl Pharmacol. 2011 Apr 15;252(2):73-84. doi: 10.1016/j.taap.2010.10.008. Epub 2010 Oct 16.

PMID:
20955723
12.

Characterization and interlaboratory comparison of a gene expression signature for differentiating genotoxic mechanisms.

Ellinger-Ziegelbauer H, Fostel JM, Aruga C, Bauer D, Boitier E, Deng S, Dickinson D, Le Fevre AC, Fornace AJ Jr, Grenet O, Gu Y, Hoflack JC, Shiiyama M, Smith R, Snyder RD, Spire C, Tanaka G, Aubrecht J.

Toxicol Sci. 2009 Aug;110(2):341-52. doi: 10.1093/toxsci/kfp103. Epub 2009 May 22.

13.

Diethylnitrosamine initiation does not alter clofibric acid-induced hepatocarcinogenesis in the rat.

Michel C, Desdouets C, Slaoui M, Isaacs KR, Roberts RA, Boitier E.

Toxicol Sci. 2007 Sep;99(1):58-69. Epub 2007 Jun 30.

PMID:
17602206
14.

Application of toxicogenomics to genetic toxicology risk assessment.

Thybaud V, Le Fevre AC, Boitier E.

Environ Mol Mutagen. 2007 Jun;48(5):369-79.

PMID:
17567850
15.

Characterization of DNA reactive and non-DNA reactive anticancer drugs by gene expression profiling.

Le Fevre AC, Boitier E, Marchandeau JP, Sarasin A, Thybaud V.

Mutat Res. 2007 Jun 1;619(1-2):16-29. Epub 2007 Feb 8.

PMID:
17374387
16.

Proteomic characterization of the effects of clofibrate on protein expression in rat liver.

Léonard JF, Courcol M, Mariet C, Charbonnier A, Boitier E, Duchesne M, Parker F, Genet B, Supatto F, Roberts R, Gautier JC.

Proteomics. 2006 Mar;6(6):1915-33.

PMID:
16470657
17.

Laboratory variability does not preclude identification of biological functions impacted by hydroxyurea.

Müller A, Boitier E, Hu T, Carr GJ, Le Fèvre AC, Marchandeau JP, Flor M, Jefferson F, Aardema MJ, Thybaud V.

Environ Mol Mutagen. 2005 Dec;46(4):221-35.

PMID:
16127667
18.
19.

2,3,7,8-Tetrachlorodibenzo-p-dioxin induces insulin-like growth factor binding protein-1 gene expression and counteracts the negative effect of insulin.

Marchand A, Tomkiewicz C, Marchandeau JP, Boitier E, Barouki R, Garlatti M.

Mol Pharmacol. 2005 Feb;67(2):444-52. Epub 2004 Oct 20.

PMID:
15496506
20.

Regulation of apoptosis by peroxisome proliferators.

Roberts RA, Michel C, Coyle B, Freathy C, Cain K, Boitier E.

Toxicol Lett. 2004 Apr 1;149(1-3):37-41. Review.

PMID:
15093246
21.

Liver gene expression profiles of rats treated with clofibric acid: comparison of whole liver and laser capture microdissected liver.

Michel C, Desdouets C, Sacre-Salem B, Gautier JC, Roberts R, Boitier E.

Am J Pathol. 2003 Dec;163(6):2191-9.

23.

Xenobiotic-metabolizing enzymes as autoantigens in human autoimmune disorders. An update.

Boitier E, Beaune P.

Clin Rev Allergy Immunol. 2000 Apr;18(2):215-39. Review. No abstract available.

PMID:
10944706
24.

Cytochromes P450 as targets to autoantibodies in immune mediated diseases.

Boitier E, Beaune P.

Mol Aspects Med. 1999 Feb-Apr;20(1-2):84-137. Review. No abstract available.

PMID:
10575654
25.

Overproduction of Cu/Zn-superoxide dismutase or Bcl-2 prevents the brain mitochondrial respiratory dysfunction induced by glutathione depletion.

Mérad-Saïdoune M, Boitier E, Nicole A, Marsac C, Martinou JC, Sola B, Sinet PM, Ceballos-Picot I.

Exp Neurol. 1999 Aug;158(2):428-36.

PMID:
10415149
26.
27.

A case of mitochondrial encephalomyopathy associated with a muscle coenzyme Q10 deficiency.

Boitier E, Degoul F, Desguerre I, Charpentier C, François D, Ponsot G, Diry M, Rustin P, Marsac C.

J Neurol Sci. 1998;156(1):41-6.

PMID:
9559985
28.

Gliomas are driven by glycolysis: putative roles of hexokinase, oxidative phosphorylation and mitochondrial ultrastructure.

Oudard S, Boitier E, Miccoli L, Rousset S, Dutrillaux B, Poupon MF.

Anticancer Res. 1997 May-Jun;17(3C):1903-11.

PMID:
9216643
29.

Third International Congress on Human Mitochondrial Pathology (Euromit III): towards a better understanding of energy metabolism disorders.

Possekel S, Boitier E, Marsac C, Degoul F.

Neuromuscul Disord. 1996 May;6(3):215-8. No abstract available.

PMID:
8784811
30.

Intrafamilial heterogeneous clinical presentation of the mitochondrial 3243 MELAS mutation; molecular investigations among four generations.

Degoul F, Diry M, Viader F, Boitier E, Marsac C, Eymard B, Romero N, Delisle MB, Lechevalier B, Chapon F.

Eur J Neurol. 1995 Dec;2(6):573-9. doi: 10.1111/j.1468-1331.1995.tb00177.x.

PMID:
24283786
31.

Impairment of the mitochondrial respiratory chain activity in diethylnitrosamine-induced rat hepatomas: possible involvement of oxygen free radicals.

Boitier E, Merad-Boudia M, Guguen-Guillouzo C, Defer N, Ceballos-Picot I, Leroux JP, Marsac C.

Cancer Res. 1995 Jul 15;55(14):3028-35.

Supplemental Content

Loading ...
Support Center